Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,307,679
-$2,665,094 QoQ
Shares Held
342,106
+0.1% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 96.8427914155262.ToString("F0")%
Shared 0.ToString("F0")%
None 3.157208584473818.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. PTCT ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in PTCT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,307,679 | 342,106 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,972,773 | 341,927 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,329,179 | 331,256 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $26,232,744 | 537,116 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $21,047,649 | 413,023 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,102,733 | 157,349 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $7,033,380 | 189,579 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,107,327 | 68,912 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $491,416 | 16,893 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $794,361 | 28,823 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,474,086 | 110,401 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,951,421 | 72,570 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,243,493 | 66,959 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,381,578 | 62,394 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $648,533 | 12,919 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $481,320 | 12,015 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,342,227 | 35,975 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $208,191 | 5,227 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $217,005 | 4,583 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $656,377 | 10,755 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,298,902 | 27,784 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,941,584 | 77,682 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $3,865,813 | 86,658 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||